Stephan Meller

Duesseldorf, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Two cases of therapy-refractory chilblain lupus erythematosus successfully treated with deucravacitinib.

Two cases of therapy-refractory chilblain lupus erythematosus successfully treated with deucravacitinib.

Journal: Lupus

Published: July 28, 2026

Erlotinib and Leflunomide Disrupt 6-Formylindolo[3,2-b]Carbazole Metabolism and Sensitize Keratinocytes to UVA Radiation-Induced Apoptosis.

Erlotinib and Leflunomide Disrupt 6-Formylindolo[3,2-b]Carbazole Metabolism and Sensitize Keratinocytes to UVA Radiation-Induced Apoptosis.

Journal: Photodermatology, photoimmunology & photomedicine

Published: February 26, 2026

JAK inhibitor treatment for non-infectious granulomatous skin diseases-A retrospective case study.

JAK inhibitor treatment for non-infectious granulomatous skin diseases-A retrospective case study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: December 30, 2025

Omalizumab Treated Urticaria Patients Display T Cell and Thrombocyte-Associated Gene Regulation.

Omalizumab Treated Urticaria Patients Display T Cell and Thrombocyte-Associated Gene Regulation.

Journal: Immunity, inflammation and disease

Published: August 05, 2024

Ofatumumab-induced severe reactivation of psoriasis in a patient with multiple sclerosis.

Ofatumumab-induced severe reactivation of psoriasis in a patient with multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: June 15, 2024

Ultraviolet radiation in the pathogenesis of lupus erythematosus

Ultraviolet radiation in the pathogenesis of lupus erythematosus

Journal: Dermatologie (Heidelberg, Germany)

Published: May 16, 2024

Steroid-dependent polyarthritis induced by immune checkpoint inhibitor therapy successfully treated with bimekizumab.

Steroid-dependent polyarthritis induced by immune checkpoint inhibitor therapy successfully treated with bimekizumab.

Journal: Immunotherapy

Published: January 24, 2024

Population-based incidence of psoriasis vulgaris in Germany: analysis of national statutory insurance data from 65 million population.

Population-based incidence of psoriasis vulgaris in Germany: analysis of national statutory insurance data from 65 million population.

Journal: Archives of dermatological research

Published: September 12, 2023

The Endogenous Dual Retinoid Receptor Agonist Alitretinoin Exhibits Immunoregulatory Functions on Antigen-Presenting Cells.

The Endogenous Dual Retinoid Receptor Agonist Alitretinoin Exhibits Immunoregulatory Functions on Antigen-Presenting Cells.

Journal: International journal of molecular sciences

Published: April 01, 2023

Gianotti-crosti syndrome after COVID-19 vaccination.

Gianotti-crosti syndrome after COVID-19 vaccination.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: August 12, 2022

Influence of FLG loss-of-function mutations in host-microbe interactions during atopic skin inflammation.

Influence of FLG loss-of-function mutations in host-microbe interactions during atopic skin inflammation.

Journal: Journal of dermatological science

Published: December 06, 2021

Risk of psoriatic arthritis depending on age: analysis of data from 65 million people on statutory insurance in Germany.

Risk of psoriatic arthritis depending on age: analysis of data from 65 million people on statutory insurance in Germany.

Journal: RMD open

Published: September 25, 2021

Showing 1-12 of 43

Last Updated: 09/26/2026